Event header image

Nordic-Baltic Conference in Pharmacovigilance 2024

8.10.2024 09:00

Original Sokos Hotel Presidentti & Live webinar

The program has now been published! The titles of the speeches as well as the speakers are being updated constantly.

The program is presented in Helsinki time. 

 

Nordic-Baltic Conference in Pharmacovigilance 2024: 8.10.2024 

 

8.30 Registration and light breakfast for on-site participants

9.00 Welcome ja opening words
Ouli Uimonen, CEO, Pharmaca Health Intelligence Oy
Ulla Partanen, Head of Learning Services, Pharmaca Health Intelligence Oy
Planning group representative

9.10 Risk management including additional risk minimization measures (aRMM)
Moderators: Jukka Pesonen, Orion Pharma and Pauliina Ehlers Pharma Industry Finland

Purpose of this session is to discuss how the legal framework for additional risk minimization is adjusted to the local setting; what are the best practices and challenges. How to ensure successful dissemination of aRMM-materials and receiving of the information? How does the process go in different countries, what about digital distribution etc.? Short 5-8 min presentations from the Nordic and Baltic competent authorities and a panel discussion. 

Discussion participants:

Line Michan, Head of the Pharmacovigilance Unit, Danish Medicines Agency
Andre Luong, Senior Advisor, Pharmacovigilance, NOMA
Jaana Santaholma, Senior Medical Officer, Head of Section, Fimea
Rasa Judickiene, Chief specialist Pharmacovigilance and Poison Information Unit, Lithuania

11.00 Lunch and networking

Moderator: Organizing committee member

12.10 Drug safety and medication safety - two sides of the coin
Anna-Ria Holmström, Assistant professor, University of Helsinki

12.35 Ecopharmacovigilance and risk management
David J Lewis, Visiting Professor, School of Life and Medical Sciences, University of Hertfordshire

13.10 Felleskatalogen, an excellent side effect search
Bente Cecilie By Jansen, Managing director, Chief editor. Felleskatalogen AS

13.35 Coffee and networking

14.10 Topic will be confirmed soon

14.35 DKMA AI project "PHAIR – Pharmacovigilance by AI Real-Time analyses"
Claus Møldrup, Director of Data Analytics Center, DKMA

15.05 Artificial Intelligence, Real-World Automation and the Safety of Medicines 
Andrew Bate, Head of Safety Innovation & Analytics, GSK 

15.50-16.00 End of conference and invitation to the next conference
Planning group representative
Ulla Partanen, Head of Learning Services, Pharmaca Health Intelligence Oy

Sometimes things change. Pharmaca reserves right for the changes on the program.

Select number of registrations
Registration
Registration ends
Price
Amount

Participant from Finland (+VAT 24%)

Registration ends 14.6.2024 23:59
445,00 € (excl. VAT 24%)

Amount:


Participant from other countries (VAT 0%)

Registration ends 14.6.2024 23:59
445,00 €

Amount:


Participant from Finland (+VAT 24%)

Registration ends 14.6.2024 23:59
445,00 € (excl. VAT 24%)

Amount:


Participant from other countries (VAT 0%)

Registration ends 14.6.2024 23:59
445,00 €

Amount:


Participant from Finland (+VAT 24%)

Registration ends 1.10.2024 23:59
545,00 € (excl. VAT 24%)

Amount:


Participant from other countries (VAT 0%)

Registration ends 1.10.2024 23:59
545,00 €

Amount:


Participant from Finland (+VAT 24%)

Registration ends 8.10.2024 08:15
545,00 € (excl. VAT 24%)

Amount:


Participant from other countries (VAT 0%)

Registration ends 8.10.2024 08:15
545,00 €

Amount:


Sisältyy 2024: Pharma

Registration ends 8.10.2024 09:00
free

Amount:


Event time

Starts:  

8.10.2024 09:00

Ends:  

8.10.2024 16:00

Event location

Original Sokos Hotel Presidentti & Live webinar

Eteläinen Rautatiekatu 4
00100 Helsinki

View larger map and directions

Contact us

 

ulla-jpeg.jfif

Ulla Partanen 

Head of Learning Services

academy@pharmaca.fi

+358 9 6150 4973

 

A larger group or unlimited access?

Ask for an offer here

 

Event partner

medfiles_logo_valkoinenm_png-id-59046-002.png

logo_pr_with_tagline_original.png

 

Interested in partnership?

Ask us about visibility and partnership options here